Characteristics | n (%) |
---|---|
Sex: (n=223) | |
Female | 101 (45.3%) |
Male | 122 (54.7%) |
Eligibility period a : (n= 223) | |
June 2004 – December 2005 | 42 (18.8%) |
January 2006 – January 2010 | 181 (81.2%) |
Age at eligibility: (n=223) | |
Median in years (IQR) | 2.9 (1.4 – 7.4) |
< 2 years | 89 (40%) |
2 – 4 years | 49 (22%) |
≥ 5 years | 85 (38%) |
HIV type: (n=223) | |
HIV-1 | 214 (95.9%) |
HIV-2 | 9 (4.0%) |
HIV-Dual | 0 |
WHO clinical stage at eligibility: (n=178) | |
1 or 2 | 63 (35.4%) |
3 or 4 | 115 (64.6%) |
CD4% at eligibility: (n=196) | |
Median (IQR) | 11 (7 – 14) |
<15% | 151 (77.0%) |
≥15% | 45 (23.0%) |
Haemoglobin at eligibility (n=192) | |
Median (IQR) | 9.3 (7.9 – 10.3) |
Haemoglobin < 8 g/dl | 50 (26%) |
Vital status of parents: (n=173) | |
One parent died | 70 (40.5%) |
Both died | 16 (9.2%) |
Both alive | 87 (50.3%) |